Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 28 ... Chiron Corporation. Winger also serves on the boards of directors of Cell Genesys, Inc., Cephalon, Inc. and Vertex Pharmaceuticals. "We are pleased to have two of the ...
2009 NOV 16 ... stocks: Microsoft Corporation (NASDAQ:MSFT), United States Steel Corp. (NYSE:X), Cephalon Inc. (NASDAQ:CEPH), Eaton Corporation (NYSE:ETN), and Harmony Gold Mining Co. Ltd. ...
2009 SEP 28 ... tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL). There are two ...
2009 NOV 23 ... The agency's healthcare clients include Amgen, Auxilium, Bayer, Becton Dickinson, Cephalon, Endo Pharmaceuticals, Life Line Screening, Mayo Clinic, Memorial Sloan-Kettering Cancer ...
2009 NOV 16 ... pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals. With nine ...
2009 NOV 16 ... pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals (now Pfizer). With ...
2009 NOV 16 ... characteristic features required for tumorigenesis. Small molecule inhibitors, such as Cephalon's CEP-701, are in phase 1 and 2 clinical trials, and a series of AstraZeneca Trk ...
2009 OCT 19 ... pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals. With nine ...
2009 NOV 2 ... 76 Gilead: diversification after market domination 80 Cephalon: a Biopharma out-licensor 83 Alnylam: a developer of novel therapeutics ...
2009 SEP 21 ... independent of the increases in startle amplitude," wrote D.G. Flood and colleagues, Cephalon, Inc. The researchers concluded: "The demonstrated efficacy of five mood ...
2009 OCT 13 ... an antero-ventral quadrant of the optic vesicle and the surrounding part of the anterior cephalon. The original dorso-ventral polarity of the transplant was once cancelled and ...
2009 NOV 2 ... support since 2003 as the Presenting Sponsor of the Awards Ceremony and Dinner, and Cephalon, Inc. is the Awards Week Sponsor and Associate Sponsor of the Awards Ceremony and ...
